Authors:
MINEUR P
MENARD JF
LELOET X
BERNARD JF
GROSBOIS B
POLLET JP
AZAIS I
LAPORTE JP
DOYEN C
DEGRAMONT A
WETTERWALD M
EULLERZIEGLER L
PENY AM
MONCONDUIT M
MICHAUX JL
Citation: P. Mineur et al., VAD OR VMBCP IN MULTIPLE-MYELOMA REFRACTORY TO OR RELAPSING AFTER CYCLOPHOSPHAMIDE-PREDNISONE THERAPY (PROTOCOL MY-85), British Journal of Haematology, 103(2), 1998, pp. 512-517
Authors:
HENIC N
PREUDHOMME C
NOEL M
LAI J
WETTERWALD M
SIMON M
FENAUX P
Citation: N. Henic et al., FREQUENCY OF MOLECULAR ELIMINATION OF PH1 CLONE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH INTERFERON-ALPHA, Leukemia, 10(1), 1996, pp. 185-186
Authors:
HEBBAR M
KAPLAN C
CAULIER MT
WATTEL E
MOREL P
WETTERWALD M
BAUTERS F
FENAUX P
Citation: M. Hebbar et al., LOW INCIDENCE OF SPECIFIC ANTIPLATETLET ANTIBODIES DETECTED BY THE MAIPA ASSAY IN THE SERUM OF THROMBOCYTOPENIC MDS PATIENTS AND LACK OF CORRELATION BETWEEN PLATELET AUTOANTIBODIES, PLATELET LIFE-SPAN AND RESPONSE TO DANAZOL THERAPY, British Journal of Haematology, 94(1), 1996, pp. 112-115
Authors:
HEBBAR M
KAPLAN C
CAULIER MT
WATTEL E
MOREL P
WETTERWALD M
BAUTERS F
FENAUX P
Citation: M. Hebbar et al., PROSPECTIVE ASSESSMENT OF THE MECHANISM OF THROMBOCYTOPENIA AND ITS TREATMENT BY DANAZOL IN MYELODYSPLASTIC SYNDROMES (MDS) - A REPORT ON 28 CASES, Blood, 86(10), 1995, pp. 3170-3170
Authors:
GROSBOIS B
MARY JY
MICHAUX JL
FACON T
LAPORTE JP
EULLERZIEGLER L
WETTERWALD M
BAUTERS F
MONTCONDUIT M
Citation: B. Grosbois et al., CONTINUOUS OR SEQUENTIAL MELPHALAN IN COMBINATION WITH INTERFERON-ALFA-2A (IFN-ALPHA-2A) AND PREDNISONE IN PATIENTS WITH MULTIPLE-MYELOMA -PRELIMINARY-RESULTS, Blood, 82(10), 1993, pp. 10000263-10000263